![](/img/cover-not-exists.png)
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
Abigerges, D, Chabot, G G, Armand, J P, Hérait, P, Gouyette, A, Gandia, DVolume:
13
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1995.13.1.210
Date:
January, 1995
File:
PDF, 1022 KB
english, 1995